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Microhomology-mediated end joining is the 
principal mediator of double-strand break 
repair during mitochondrial DNA lesions
ABSTRACT Mitochondrial DNA (mtDNA) deletions are associated with various mitochondrial 
disorders. The deletions identified in humans are flanked by short, directly repeated mito-
chondrial DNA sequences; however, the mechanism of such DNA rearrangements has yet to 
be elucidated. In contrast to nuclear DNA (nDNA), mtDNA is more exposed to oxidative 
damage, which may result in double-strand breaks (DSBs). Although DSB repair in nDNA is 
well studied, repair mechanisms in mitochondria are not characterized. In the present study, 
we investigate the mechanisms of DSB repair in mitochondria using in vitro and ex vivo as-
says. Whereas classical NHEJ (C-NHEJ) is undetectable, microhomology-mediated alternative 
NHEJ efficiently repairs DSBs in mitochondria. Of interest, robust microhomology-mediated 
end joining (MMEJ) was observed with DNA substrates bearing 5-, 8-, 10-, 13-, 16-, 19-, and 
22-nt microhomology. Furthermore, MMEJ efficiency was enhanced with an increase in the 
length of homology. Western blotting, immunoprecipitation, and protein inhibition assays 
suggest the involvement of CtIP, FEN1, MRE11, and PARP1 in mitochondrial MMEJ. Knock-
down studies, in conjunction with other experiments, demonstrated that DNA ligase III, but 
not ligase IV or ligase I, is primarily responsible for the final sealing of DSBs during mitochon-
drial MMEJ. These observations highlight the central role of MMEJ in maintenance of mam-
malian mitochondrial genome integrity and is likely relevant for deletions observed in many 
human mitochondrial disorders.
INTRODUCTION
Maintenance of genomic integrity is of prime importance for cel-
lular function and survival in all organisms. Endogenous and ex-
ogenous insults generate DNA damage in the nucleus and other 
organelles of living cells (Boesch et al., 2011; Gostissa et al., 
2011). Of the various types of DNA damage, DNA double-strand 
breaks (DSBs) pose the most serious threat to the genome 
(Deriano and Roth, 2013), and failure to repair such lesions could 
lead to chromosomal rearrangement, disease, or cell death 
(Khanna and Jackson, 2001; Lieber et al., 2006; Nambiar et al., 
2008; Srivastava et al., 2012; Bunting and Nussenzweig, 2013). 
DSBs can be generated by exogenous factors such as ionizing 
radiation and chemotherapeutic agents. Endogenous mediators 
of DSBs include free radicals and enzymatic processes (Weterings 
and Chen, 2008; Lieber, 2010).
Repair of DSBs is mediated by either the classical nonhomolo-
gous DNA end-joining (NHEJ) pathway or homologous recombina-
tion (HR). HR restores the original DNA sequence using DNA from 
an intact sister chromatid as a template. Although error-prone, 
NHEJ also helps to maintain genome function (Moore and Haber, 
1996; Jackson, 2002; Hefferin and Tomkinson, 2005; Wyman and 
Kanaar, 2006; Corneo et al., 2007; Yan et al., 2007; Lieber, 2010). 
Classical NHEJ (C-NHEJ) repairs DSBs in all phases of the cell cycle 
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alterations in mitochondria, the mechanisms underlying lesional re-
pair in mitochondria are of great importance. Preliminary studies 
have suggested a potential role for HR activity in mitochondria 
(Kajander et al., 2001; D’Aurelio et al., 2004). However, other DSB 
repair pathways, such as C-NHEJ and MMEJ, have yet to be ex-
plored in the context of mtDNA. The observed microhomology re-
gions associated with deletions in patients indicate a potential role 
for NHEJ in maintenance of the mitochondrial genome. In addition, 
the protein machinery involved in mitochondrial DSB repair requires 
further characterization.
In the present study, we report that whereas classical NHEJ is 
undetectable in both rodents and human mitochondria, MMEJ is 
critical for DSB repair in mtDNA. Whereas the minimum homology 
required for MMEJ was 5 nucleotides (nt), an increase in micro-
homology length enhanced efficiency. Robust induction of several 
proteins involved in DSB repair was observed in mitochondria of 
rodent tissues and human cells. Immunoprecipitation and inhibitor 
studies in rodents showed that the observed MMEJ in mitochondria 
depends on CtIP, FEN1, MRE11, and poly(ADP-ribose) polymerase 
(PARP1). Antisense RNA-mediated knockdown of DNA ligases in 
HeLa cells showed that ligase III, but not ligase IV or ligase I, is im-
portant for MMEJ in mitochondria.
RESULTS
Mitochondrial proteins do not support joining of DSBs 
by C-NHEJ
To test whether mammalian mitochondria possess the protein ma-
chinery to repair double-stranded DNA breaks through C-NHEJ, we 
studied mitochondrial protein extracts in a DSB repair assay. Mito-
chondrial protein extracts from the brain, testes, spleen, and kidney 
of rats were analyzed for purity by immunoblotting using specific 
markers (Figure 1, A and B). Results confirmed the presence of the 
specific mitochondrial markers VDAC and cytochrome C proteins 
in mitochondrial extracts, but not cytoplasmic extracts (Figure 1A). 
Expression of β-actin served as loading control (Figure 1B). To 
exclude nuclear contamination of the mitochondrial extracts, we 
tested for the presence of PCNA, a nucleus-specific protein. 
Whereas robust expression was seen in cell-free extracts (CFEs), 
PCNA was undetectable in mitochondrial extracts (Figure 1B).
The ability of mitochondrial proteins to support classical NHEJ 
was tested by incubating extracts with double-stranded (ds) oligo-
meric DNA that mimic endogenous DSBs (Figure 1C). We incu-
bated [γ-32P]ATP end-labeled ds oligonucleotides containing unique 
end structures (5′ overhangs, noncompatible [5′-5 and 5′-3′] and 
blunt ends; 2 or 6 h) with mitochondrial protein extracts from testes, 
brain, spleen, and kidney of rats and resolved purified products in 
denaturing PAGE gels (Supplemental Figure S1A). Whole-cell ex-
tracts (WCEs) prepared in parallel from the respective tissues served 
as controls. Results showed that whereas WCEs catalyzed efficient 
end joining, resulting in dimers, trimers, and other multimers, mito-
chondrial proteins failed to do so irrespective of the type of DSB 
(Figure 1, D–G) or quantity of extracts used (Supplemental Figure 
S2, A and B). When incubated with CFE, the overall joining effi-
ciency depended on the nature of DSB used and was maximal with 
5′-compatible ends (Figure 1, D–G). In contrast, when mitochondrial 
extracts (MEs) were used, end joining was seen exclusively with tes-
tes ME using a 5′-compatible substrate (Figure 1E) that does not 
require any processing before ligation. Of importance, there was no 
detectable joining when mitochondrial proteins were incubated 
with noncompatible or blunt-end DNA substrates, irrespective of 
the source of tissue extracts (Figure 1, D–G). This does not, how-
ever, rule out the possibility of weak end joining at very high 
except the M phase, whereas HR activity is restricted to late S and 
G2 phases (Lieber et al., 2003; Ciccia and Elledge, 2010; Orthwein 
et al., 2014).
It is now evident that an alternative NHEJ (A-NHEJ) operates in 
human and yeast cells (Riballo et al., 2004; Wang et al., 2006), which 
may be genetically deficient for one or more factors that are critical 
for C-NHEJ (Boulton and Jackson, 1996; Kabotyanski et al., 1998; Li 
et al., 2008). The junctions created by A-NHEJ are often associated 
with larger deletions and use of microhomology, and hence it is al-
ternatively described as microhomology-mediated end joining 
(MMEJ; Deriano and Roth, 2013). It is likely that MMEJ is indeed a 
subset of A-NHEJ.
Proteins that mediate MMEJ participate in end resection and 
stabilization of paired intermediates using microhomologies. In 
addition, specific nucleases remove 5′ and 3′ overhangs to enable 
ligation by DNA ligase I or ligase III. Although the precise mecha-
nistic aspects of the pathway are not entirely clear, the enzymatic 
and microhomology requirements of MMEJ have been described 
(Nussenzweig and Nussenzweig, 2007; Sharma et al., 2015). 
Recent studies suggest that MMEJ is operational even when C-
NHEJ is functionally active (Nussenzweig and Nussenzweig, 2007; 
Sharma et al., 2015).
The MMEJ pathway is considered less faithful than C-NHEJ and 
has been implicated in generation of chromosomal rearrangements 
in progenitor B-cell tumors of mice doubly deficient for XRCC4 or 
ligase IV and p53. Such observations have not yet been confirmed 
in human cells (Roth, 2002; Zhu et al., 2002; Ghezraoui et al., 2014). 
It is not clear whether MMEJ represents a defined and linear path-
way or a myriad of pathways that use microhomologies (Deriano 
and Roth, 2013).
Mitochondria are essential organelles that generate energy 
through oxidative phosphorylation and are often described as the 
powerhouses of the cell (Wallace, 2005). Uniquely, mitochondria en-
capsulate their own DNA (mtDNA) and are semiautonomous. The 
mammalian mitochondrial genome comprises of 2–10 copies of cir-
cular, negatively supercoiled, double-stranded DNA. Mitochondrial 
DNA is just as prone to damage as nuclear DNA and relies on im-
port of nuclear proteins involved for repair (Bohr, 2002).
Mitochondrial DNA is more prone to damage due to frequent 
exposure to reactive oxygen species (ROS) generated by mitochon-
drial oxidative phosphorylation and lack of protective histones (Chen 
et al., 2011). Consequently, mtDNA accumulates mutations at a 10- 
to 50-fold higher rate than nuclear DNA (Yakes and Van Houten, 
1997; Hudson et al., 1998; Michikawa et al., 1999; Pakendorf and 
Stoneking, 2005). The importance of mtDNA integrity is evidenced 
by the increasing mutations, deletions, inversions, and complex rear-
rangements linked to various heritable human disease syndromes 
(Falk and Sondheimer, 2010). In addition, mtDNA rearrangements 
and large-scale deletions are associated with cancer and aging 
(www.mitomap.org/MITOMAP). More than 100 unique mtDNA de-
letions have been identified in patients with mitochondrial dysfunc-
tion (Holt et al., 1988; Servidei, 2003; www.mitomap.org/bin/view.pl/
MITOMAP/DeletionsMultiple). Of interest, 85% of mtDNA deletions 
are flanked by short, directly repeated sequences and are implicated 
in aging (Eshaghian et al., 2006; Meissner et al., 2008), cancer (Abnet 
et al., 2004; Wu et al., 2005; Tseng et al., 2006; Chen et al., 2011), 
Kearns–Sayre syndrome, myopathies, progressive external ophthal-
moplegia (Schon et al., 1989; Degoul et al., 1991; Ballinger et al., 
1992), diabetes, and deafness (Ballinger et al., 1992).
Although base excision repair has been extensively studied 
in the context of mtDNA, very little is known about DSB repair in 
mitochondria. Because DSBs are a prerequisite for many DNA 
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that MEs do not support end-to-end joining of nonligatable broken 
DNA, suggesting the lack of a functionally operative C-NHEJ in 
mitochondria.
concentrations of MEs. Nonetheless, MEs possessed no classical 
end-joining activity at a range of concentrations for which CFEs 
showed proficient C-NHEJ–mediated repair. Thus our results show 
FIGURE 1: Comparison of efficiency of classical NHEJ in cell-free extracts and in mitochondrial extracts prepared from 
various rat tissues. (A, B) Evaluation of purity of mitochondrial extracts. Mitochondrial and cell-free extracts were 
prepared from rat tissues (brain, testes, spleen, kidney) and analyzed for specific markers by Western blotting. CE, 
cytoplasmic extract; ME, mitochondrial extract. CEs and MEs were probed with VDAC and cytochrome C (mitochondrial 
markers), with β-actin as loading control (A). PCNA and β-actin (nuclear and CFE markers, respectively) were used as the 
markers to test the purity of fractions. (C) Schematic representation of the oligomeric substrates (5′ compatible, 
noncompatible [5′-5 and 5′-3′], and blunt ends) mimicking endogenous DSBs used for the study. (D–G) Bar diagrams 
showing quantification of the end-joined products from mitochondrial extracts from the brain (D), testes (E), spleen (F), 
and kidney (G) using 5′-compatible, noncompatible, and blunt ends. WCE extracts from respective rat tissues were used 
as positive control. For NHEJ assay, 5-μg extracts were incubated with [γ-32P]ATP-labeled oligomeric DNA substrate for 
2 h at 30°C (testis) or 37°C. The reaction products were deproteinized and resolved on 8% denaturing PAGE. For 
quantification, the highest photostimulated light unit (PSLU) value of end joining was taken as 100%, and the relative 
efficiency between different extracts was calculated. Experiments were repeated a minimum of three times.
5’ overhangs (compatible ends)
TSK1
TSK2
blunt ends 
5’- 5’ overhangs (noncompatible ends)
5’- 3’ overhangs (noncompatible ends) 
+ gatcCG3’
5’
Cctag
G
5’
3’
VK7
VK8
TSK1
VK11
TSK1
VK13
gatcC5’
3’G Cttaa
G
5’
3’+
5’gggC
3’cccG
Gccc
Cggg 5’
3’+
5’gatcC
3’G
Ctgag
G 5’
3’+
5’gggC
3’cccG
Gccc
Cggg 5’
3’
gatcC
G3’
5’
Cctag
G
5’
3’
gatcC5’
3’G Cttaa
G
5’
3’
5’gatcC
3’G
Ctgag
G 5’
3’
VDAC
Cytochrome C
β-Actin
CE
ME
+ -- ++ --
-- ++ +
21 43 76 85
+
-- +
SpleenTestesBrain Kidney
21 43 76 85
PCNA
β-Actin
21 43 76 8
CFE
ME
+ -- ++ --
-- ++ +
5
+
-- +
SpleenTestesBrain Kidney
21 43 76 85
A 
C 
B 
Cellular EJ Mitochondrial EJ
0
50
100
5'-5' C
5'-5' NC
5'-3' NC
BE
Brain
Ef
fic
ie
nc
y 
of
 J
oi
ni
ng
 (%
)
Cellular EJ Mitochondrial EJ
0
50
100
5'-5' C
5'-5' NC
5'-3' NC
BE
Testes
Ef
fic
ie
nc
y 
of
 J
oi
ni
ng
 (%
)
Cellular EJ Mitochondrial EJ
0
50
100
5'-5' C
5'-5' NC
5'-3' NC
BE
Spleen
Ef
fic
ie
nc
y 
of
 J
oi
ni
ng
 (%
)
Cellular EJ Mitochondrial EJ
0
50
100
5'-5' C
5'-5' NC
5'-3' NC
BE
Kidney
Ef
fic
ie
nc
y 
of
 J
oi
ni
ng
 (%
)
D 
E 
F 
G 
226 | S. K. Tadi et al. Molecular Biology of the Cell
MMEJ assay was performed by incubating 5 μg of mitochondrial 
protein extracts (derived from rat brain, testes, spleen, or kidney) 
with ds DNA containing DSBs flanked by direct repeats (2 h at 25°C), 
and the end-joined products were resolved in 8% denaturing PAGE 
gels. Of interest, a distinct 63-nt band (Figure 2B, arrow) was ob-
served upon incubation with mitochondrial extracts (from the brain, 
testes, spleen, and kidney), suggesting functional microhomology-
mediated end joining. Of interest, we did not find any major differ-
ences between individual tissue extracts in the efficiency of MMEJ 
catalyzed (Figure 2, B and C). Of importance, and consistent with 
the foregoing results, we did not observe any joined products that 
could be attributed to functional C-NHEJ in mitochondria. However, 
Mitochondrial extracts possess efficient MMEJ
Given that there was no detectable C-NHEJ in mitochondria, we 
wondered whether DSB repair was mediated through an alternative 
microhomology-dependent joining pathway. To test this hypothesis, 
we designed two oligomeric ds DNAs harboring 13-nt direct re-
peats (microhomology; Figure 2A). On joining by MMEJ, these mi-
crohomology regions can be cleaved using XcmI-mediated restric-
tion endonuclease digestion. The sequential steps involved in the 
MMEJ assay are outlined in Supplemental Figure S1B. After “radio-
active” PCR amplification, a 63–base pair fragment is expected if 
joining is mediated through MMEJ, whereas higher–molecular 
weight products indicate either C-NHEJ or MMEJ (Figure 2A). The 
FIGURE 2: Evaluation of microhomology-mediated DNA end joining in MEs prepared from rat tissues. (A) Schematic 
presentation of the microhomology (13 nt) containing substrate used and expected MMEJ reaction product (63 base 
pairs) after PCR amplification. Region of microhomology is indicated in blue and red in the substrates. (B) Denaturing 
PAGE profile showing MMEJ observed after PCR amplification catalyzed by MEs from rat brain, testes, spleen, and 
kidney. Cell-free extracts from respective tissues served as the control. The arrow indicates expected 63-nt-long dimeric 
product resulting from MMEJ. Other bands above the MMEJ product are due to microhomology-independent NHEJ 
products. M, 60-nt marker. For MMEJ assay, 5-μg extracts were incubated with oligomeric ds DNA substrates for 2 h at 
25°C, and the end-joined products were PCR amplified using [γ-32P]ATP- labeled primers and resolved on 8% denaturing 
PAGE. (C) Bar diagram showing quantification of the end-joined products based on multiple experiments. The efficiency 
of the joining was calculated. For quantification, the highest PSLU value of C-NHEJ or MMEJ was taken as 100%, and 
the relative efficiency within different extracts was calculated. (D) XcmI digestion of MMEJ products of mitochondrial 
extracts from the brain, testes, spleen, and kidney. XcmI digestion depends on recreation of the microhomology region 
upon joining, as indicated in A. MMEJ products were incubated with XcmI (5 U/10 μl reaction) at 37°C for 2 h, and the 
products were resolved on 8% denaturing PAGE. (E) Cloning and sequencing of MMEJ junctions derived from 
mitochondria of testes, spleen, and kidney. The nucleotides in blue represent the retained microhomology region, and 
red shows deletion. Green represents the junction between random sequence and the start of microhomology. Pink 
indicates mutations. All NHEJ junctions shown are from different clones and are derived from independent PCR and 
transformations. (F) Mechanism of MMEJ based on sequence analysis.
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cell-free extracts, it was undetectable in the case of mitochondrial 
extracts (Figure 3C). Furthermore, XmnI digestion confirmed that 
the band corresponding to MMEJ indeed used microhomology for 
joining (Figure 3E). In addition, sequencing analyses of the joined 
junctions confirmed the use of microhomology regions (Supple-
mental Figure S3, A and B). In summary, our results suggest that 
mitochondrial extracts can catalyze MMEJ and the efficiency of the 
joining depends on the distance between the microhomology and 
DSB termini.
MMEJ catalyzed by mitochondrial extracts depends on CtIP, 
FEN1, ligase III, MRE11, and PARP1
To understand the mechanisms of DSB joining in mitochondria, we 
examined the presence of critical C-NHEJ and MMEJ proteins in 
mitochondrial extracts by Western blotting (Figure 4, A and B). Mito-
chondrial extracts from the brain, testes, spleen, and kidney were 
analyzed for expression of classical NHEJ proteins using β-actin as 
loading control (Figure 1B). Immunoblots showed no bands corre-
sponding to the expected positions of KU70, KU80, POL λ, ligase IV, 
and XLF in most of the mitochondrial extracts, whereas robust ex-
pression was observed in cell-free extracts (Figure 4A). The abun-
dance of DNA-dependent protein kinase catalytic subunit (DNA-
PKcs), however, was comparable in mitochondrial and respective 
cell-free extracts. Of interest, we observed variable expression of 
PARP1 in mitochondrial tissue extracts (Figure 4B). In addition, we 
detected expression of ligase III and CtIP in all the mitochondrial 
extracts tested, whereas FEN1 expression was restricted to brain and 
testes. Although weak expression of MRE11 and RAD50 was ob-
served in mitochondrial extracts from the tissues tested, NBS1 was 
undetectable (Figure 4B). For many proteins, we found multiple or 
variable band patterns in MEs compared with their CFE counter-
parts. To test the identity of these bands, we performed Western 
blots of proteins such as KU70, KU80, DNA-PK, and ligase IV after 
immunoprecipitation (Supplemental Figure S4). Although most of 
the bands identified with respective antibodies suggest specificity, 
further characterization of the significance of the multiple observed 
bands is beyond the scope of this study.
To characterize the protein machinery involved in observed 
MMEJ, we performed immunoprecipitation (IP) of distinct DSB pro-
teins from mitochondrial extracts prepared from rat testes. Immuno-
depletion was confirmed by Western blot analysis, and β-actin 
served as the loading control (Figure 5A and Supplemental Figure 
S5, A and B). A significant reduction in microhomology-mediated 
joining (13 nt) was observed upon incubation with extracts after CtIP, 
FEN1, ligase III, MRE11, or PARP1 was immunodepleted (Figure 5, 
B and C). There was no significant reduction in the MMEJ efficiency 
when classical NHEJ proteins such as DNA-PKcs, KU70, and KU80 
were immunodepleted (Figure 5, B and C). However, studies using 
complementation of proteins to the depleted extracts will be re-
quired to delineate the order and specificity of proteins involved in 
catalyzing MMEJ in the context of mtDNA.
We next studied the effects of established chemical inhibitors of 
DSB repair on MMEJ of mtDNA. Mitochondrial extracts were prein-
cubated with inhibitors of phosphoinositide 3-kinase (PI3K; wort-
mannin), DNA-PK (NU7026), pATM (KU55933), ligase I (L182), 
MRE11 (mirin), and PARP1 (3-aminobenzamide [3-ABA]) and sub-
jected to MMEJ assay. Results showed that there was no significant 
difference in MMEJ efficiency in the presence of wortmannin, 
NU7026, KU55933, and L182, ruling out the involvement of DNA-
PKcs, ATM, and ligase I in MMEJ (Figure 5, D–F, I, and Supplemental 
Figures S6 and S7). Of interest, a concentration-dependent de-
crease in MMEJ efficiency was observed in the presence of mirin 
when cell-free extracts were used for the study, joined products con-
sistent with both MMEJ and C-NHEJ were observed, in keeping 
with our previous observations (Sharma et al., 2015; Figure 2, B and 
C). Hence our results suggest that whereas cell-free extracts use 
both C-NHEJ and MMEJ for end joining of DSBs, mitochondrial 
extracts catalyze joining exclusively through MMEJ.
To confirm the requirement of microhomology for end joining 
catalyzed by mitochondrial proteins, we performed an XcmI restric-
tion enzyme digestion (Figure 2D). On digestion with XcmI, a band 
corresponding to 63 nt formed due to MMEJ was cleaved both in 
the case of MEs and CFEs, showing microhomology-mediated end 
joining, albeit with different efficiency (Figure 2D). To confirm further 
the use of microhomology at the sequence level, we PCR amplified, 
cloned, and sequenced the joined junctions. Sequencing analyses 
of a number of independent clones showed that in all cases the 
deletion used the direct repeats in mitochondria (Figure 2, E and F). 
Perfect microhomology was seen in 68% of clones (19 of 28, derived 
from testes, spleen, and kidney), whereas 32% were joined with one 
or two mismatches (Figure 2E). These mismatches or mutations 
likely explain the partial cleavage of the joined products by XcmI 
digestion.
Efficiency of MMEJ in mitochondria depends on the length 
of microhomology
Because efficient MMEJ was observed in mitochondrial extracts, we 
next focused on the effect of microhomology length on joining. To 
address this, we performed a joining assay with oligomeric DNA 
substrates possessing DSBs flanked by microhomology lengths of 3, 
5, 8, 10, 13, 16, 19, and 22 base pairs, using mitochondrial protein 
extracts prepared from rat testes. Results showed that the efficiency 
of MMEJ improved with increasing length of microhomology (Figure 
3, A–D). Of interest, a microhomology length of 3 nt did not support 
MMEJ in mtDNA, and the efficiency was weak when 5-nt micro-
homology was used (Figure 3, A and B). A microhomology length–
dependent increase in MMEJ efficiency was also observed with cell-
free extracts, which is consistent with our previous study (Sharma 
et al., 2015). Taken together, our results demonstrate that, unlike 
whole cells, mitochondria are devoid of functional C-NHEJ but in-
stead possess MMEJ activity, which is dependent on the length of 
microhomology.
Relative positioning of the microhomology region with the 
DSB affects MMEJ efficiency
Use of microhomology by alternative NHEJ leads to extensive dele-
tions at the junctions (Sharma et al., 2015). Thus we sought to un-
derstand the effect of spacing between the microhomology region 
and DNA termini. For this, we designed distinct oligomeric DNA 
substrates containing 8-nt microhomology regions but positioned 
internally either 8 or 24 nt from the terminus. These microhomology 
regions can be cleaved by XmnI restriction digest of the micro-
homology- mediated joining products (as described earlier for 
XcmI in the case of 13-nt microhomology substrates). A joining as-
say using mitochondrial protein extracts from rat testes showed ef-
ficient MMEJ joining when the microhomology was positioned 8 nt 
from the DSB (Figure 3, E and F). MMEJ efficiency was significantly 
compromised when the microhomology was positioned 24 nt from 
the DSB (Figure 3, E and F). However, when the microhomology 
was 24 nt from the terminus in one of the DNA substrates, we ob-
served efficient MMEJ (Figure 3, E and F). A similar pattern of 
MMEJ efficiency was observed when the foregoing permutations 
of substrates were incubated with cell-free testes extracts. Of im-
portance, despite the remarkable overall efficiency of C-NHEJ with 
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FIGURE 3: Evaluation of length and position of microhomology on efficiency of MMEJ in mitochondria. (A) Gel profile 
showing efficiency of MMEJ in mitochondrial extracts when length of microhomology is 3, 5, 8, or 10 nt. (B) Bar diagram 
showing quantification of MMEJ and C-NHEJ products shown in A. Graph is a cumulative representation of three 
independent repeats. For quantification, highest PSLU value of C-NHEJ or MMEJ was taken as 100%, and the relative 
efficiency between different extracts or substrates was calculated. (C) Denaturing PAGE profile showing efficiency of 
MMEJ in mitochondrial extracts when the length of the microhomology is 13, 16, 19, or 22 nt. (D) Bar graphs 
representing quantification of the C-NHEJ and MMEJ products shown in C. In all cases, cell-free extracts from testes 
served as the control. For quantification, the highest PSLU value of C-NHEJ or MMEJ was taken as 100%, and the 
relative efficiency between different extracts or substrates was calculated. (E) Comparison of MMEJ efficiency of 
mitochondrial extracts when an 8-nt microhomology region was positioned at different lengths from a DSB. Here, 8+8 
indicates that the distance between the microhomology and DSB is 8 nt in both substrates; 24+24, that the distance 
between microhomology and DSB is 24 nt in each substrate; and while 8+24 and 24+8 that the distance is either 8 or 
24 nt as indicated. DNA substrates were designed in such a way that microhomology- mediated joining creates a 
restriction site for XmnI. The band at 50 nt is contributed by random primer extension of unused DNA substrates where 
radiolabeled primer can bind. (F) Bar diagram showing quantification of the end-joined products of the gels shown in E. 
In all cases, MMEJ products are indicated by arrows, and C-NHEJ products are bracketed. For quantification, the 
highest PSLU value of C-NHEJ or MMEJ was taken as 100%, and the relative efficiency between different extracts or 
substrates was calculated. M′, γ-32P–labeled 50-nt ladder; M, labeled 60-nt oligomer.
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for cellular survival. When DSBs are induced in mitochondria by re-
striction endonucleases, both intramolecular and intermolecular 
recombination products with large deletions are observed (Fukui 
and Moraes, 2009). Although homologous recombination could be 
one of the potential pathways of mtDNA DSB repair to ensure sta-
bility of the genome, evidence to this end in mitochondria is lack-
ing. The mechanisms underlying mitochondrial instability and the 
ensuing repair processes remain unclear. Various studies have sug-
gested involvement of proteins such as retinoblastoma protein, 
BRCA1 (Coene et al., 2005), p53 (Ferecatu et al., 2009), CtBP (Kim 
and Youn, 2009), FEN (Liu et al., 2008; Szczesny et al., 2008; Kalifa 
et al., 2009), DNA ligase III (De and Campbell, 2007; Gao et al., 
2011; Simsek et al., 2011), MRE11 (Dmitrieva et al., 2011; Kalifa 
et al., 2012), PARP1 (Rossi et al., 2009; Lapucci et al., 2011), and 
KU80 (Coffey and Campbell, 2000) in the maintenance of mtDNA 
integrity over and above their roles in ensuring nuclear genomic 
homeostasis.
Mitochondria possess efficient MMEJ but lack 
classical NHEJ
Our results provide compelling evidence that mitochondrial protein 
extracts prepared from distinct rat tissues and HeLa cells possess 
efficient microhomology-mediated joining activity. Of interest, the 
mitochondrial extracts were unable to catalyze joining through the 
classical NHEJ pathway, irrespective of the type of DSB studied. 
The efficiency of the MMEJ improved when the length of the micro-
homology region was increased, which is consistent with our recent 
study (Sharma et al., 2015). In addition, it appears that the spacing 
between the microhomology region and DSB is likely critical in 
determining joining efficiency. When microhomology was placed 
farther from the DNA terminus, joining efficacy was low.
To ensure that the unique observation in our study was not due 
to potential nuclear contamination in the mitochondrial extracts, we 
paid particular attention to exclude this possibility. First, mitochon-
drial proteins were isolated using two independent methods, and in 
and 3-ABA, further confirming the roles of MRE11 and PARP1 in 
mitochondrial MMEJ (Figure 5, G and H, and Supplemental Figure 
S7, B and C). In addition, when wortmannin and NU7026 were used, 
both inhibitors inhibited C-NHEJ, whereas MMEJ was unaffected, 
indicating the specificity of the inhibitors (Supplemental Figure S6).
Hence our studies using IP experiments in conjunction with in-
hibitor studies suggest that the MMEJ in mitochondria is dependent 
on CtIP, FEN1, ligase III, MRE11, and PARP1.
DNA ligase III, but not ligase IV, is involved in mitochondrial 
MMEJ
Because ligase I inhibitor did not show any effect on mitochondrial 
MMEJ, we focused our attention on the likely involvement of ligase 
III in catalyzing mitochondrial MMEJ. Owing to the lack of ligase 
III–knockout mice, we resorted to knockdown experiments in the 
HeLa cell line using human ligase III antisense plasmids. Purity and 
knockdown were confirmed in both mitochondrial and nuclear ex-
tracts by Western blot analysis (Figure 6, A and B). A significant re-
duction in microhomology-associated joining was observed when 
mitochondrial extracts prepared after ligase III knockdown was used 
(Figure 6C), in contrast to extracts prepared from a mock-transfected 
cell line. To additionally confirm that the mitochondrial MMEJ activ-
ity is indeed dependent on ligase III but not ligase IV in vivo, we 
knocked down the latter in HeLa cells using antisense RNA. The 
knockdown of ligase IV was confirmed by Western blotting in two 
independent transfections in both cell-free and mitochondrial ex-
tracts (Figure 6D). Of interest, ligase IV knockdown resulted in re-
duction of C-NHEJ–mediated product formation catalyzed by CFE 
but not MMEJ activity as compared with mock-transfected controls 
(Figure 6, E and F). Thus these results confirm that ligase III and not 
ligase IV is responsible for MMEJ in mammalian mtDNA.
DISCUSSION
The integrity of mtDNA plays a critical role in maintaining cellular 
homeostasis, and efficient repair of mtDNA damage is important 
FIGURE 4: Immunoblot analyses showing the presence and level of expression of DSB repair proteins in mitochondria 
of various rat tissues. (A) Comparison of level of expression of C-NHEJ proteins in mitochondrial extracts and CFE 
prepared from rat tissues. The ∼30-μg extracts from the brain, testes, spleen, and kidney were resolved on 8–10% 
SDS–PAGE, transferred to polyvinylidene fluoride membrane, and probed using the respective antibodies. (B) Presence 
and expression of MMEJ and other DSB repair proteins in mitochondrial extracts of various tissues and corresponding 
whole-cell extracts.
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mtDNA integrity (Gao et al., 2011; Simsek et al., 2011; Oh et al., 
2014). Our study now suggests the additional involvement of 
PARP1, CtIP, and MRE11 in mitochondrial MMEJ.
Although we detected the presence of proteins responsible for 
MMEJ by immunoblotting of mitochondria, the mechanism by 
which these proteins are transported to mitochondria remains ill 
defined. Most of them lack a conventional mitochondrial localiza-
tion signal (MLS), despite their presence in mitochondria. Of inter-
est, ligase III, which we show is critical for MMEJ in mitochondria, is 
known to have an alternative translation initiation mechanism, 
which produces proteins with or without MLS from the same mRNA 
(Lakshmipathy and Campbell, 1999). Although we could not 
identify any obvious MLS sequences in other proteins involved in 
mitochondrial MMEJ, the existence of additional mitochondrial 
mechanism(s) cannot be ruled out. It is hence intriguing that we did 
observe multiple bands/differences for individual proteins by West-
ern blot analyses in MEs compared with their CFE counterparts. 
Although IP confirmed the specificity of these bands, the signifi-
cance of this observation is worth pursuing.
each case, purity was confirmed by immunoblotting using specific 
mitochondrial and nuclear markers. Second, irrespective of the 
method used, mitochondrial protein extracts exhibited similar DSB 
repair activity (robust MMEJ but not C-NHEJ). Third, we believe that 
even trace nuclear protein contamination would have resulted in C-
NHEJ, which was only evident with CFE. As further confirmation, the 
mitochondrial extracts prepared from human HeLa cells showed ef-
ficient MMEJ but were devoid of C-NHEJ activity (limited to DSBs 
with 5′-compatible overhangs; unpublished data). We hence pro-
pose that the observed exclusive MMEJ activity is indeed of mito-
chondrial origin and not due to any nuclear contamination.
Mitochondrial MMEJ depends on ligase III
In our studies, we observed mitochondria-specific expression of li-
gase III, PARP1, CtIP, MRE11, and RAD50 in rat tissues. Immunopre-
cipitation and antisense RNA-mediated knockdown in conjunction 
with specific inhibitors demonstrated that the DNA ligase responsi-
ble for MMEJ in mitochondria is ligase III. This observation is in line 
with previous reports suggesting that ligase III is indispensible for 
FIGURE 5: Efficiency of mitochondrial MMEJ after immunodepletion and inhibitor-based inactivation of C-NHEJ and 
alternate NHEJ proteins. (A) Bar diagrams showing the quantification of efficiency of immunodepletion in mitochondrial 
extracts. β-Actin was used as loading control. (B) Evaluation of efficiency of MMEJ in mitochondrial extracts after 
immunodepletion assayed using 13-nt microhomology substrates. (C) Bar diagram showing quantitation of MMEJ 
efficiency in immunodepleted rat tissue mitochondrial extracts based on multiple gels. For quantification, the relative 
intensity of the MMEJ band between different samples was calculated and expressed as PSLU. (D–I) Comparison of the 
effect of repair inhibitors against ATM kinase (KU55933), DNA-PK (NU7026), ligase I (L82), PI3K (wortmannin), MRE11 
(mirin), and PARP1 (3-ABA) on MMEJ of 13-nt microhomology substrates. For quantification, the relative intensity of the 
MMEJ band between different samples was calculated and is expressed as PSLU (bar graphs). We preincubated 1- to 
2-μg rat tissue mitochondrial extracts with inhibitors with increasing concentration (10 μM to 10 mM) for 30 min on ice 
and subjected them to MMEJ assay for 2 h at 25°C. The end-joined products were PCR amplified using γ-32P–labeled 
primers and resolved on 8% denaturing PAGE. In the case of control reactions, for which inhibitor was not added, and 
equal concentration of DMSO was used (see Supplemental Figure S7 for details). *p < 0.05, **p < 0.01, ***p < 0.001. 
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at the MMEJ junctions and efficient use of microhomology regions 
by mitochondrial proteins bore a striking similarity to deletions ob-
served within the mitochondrial DNA of patients with mitochondrial 
dysfunction. Of interest, among >100 types of mitochondrial DNA 
deletions reported, at least 85% are flanked by short, directly re-
peated sequences and are implicated in aging, cancer, mitochon-
drial syndromes, and other diseases (Schon et al., 1989; Degoul 
et al., 1991; Ballinger et al., 1992; Abnet et al., 2004; Wu et al., 
2005; Eshaghian et al., 2006; Tseng et al., 2006; Meissner et al., 
2008; Chen et al., 2011). One of the hallmarks of the observed 
mitochondrial genome rearrangement was interstitial deletion 
between two direct repeat sequences in such a way that one of the 
repeats was retained after breakage and rejoining. Hence the 
Base excision repair (BER) has been well studied in the repair that 
follows oxidative damage in mitochondria (Svilar et al., 2011). Iso-
forms of the nuclear BER proteins have been reported in mitochon-
dria in diverse organisms (Boesch et al., 2011). Therefore it is possi-
ble that, as with BER proteins, some of the nuclear DSB repair 
proteins are also targeted to resolve breaks in mitochondrial DNA.
Mitochondrial DNA deletions in human patients can be 
explained by MMEJ-mediated repair
By using a cloning and sequencing strategy, we showed the use of 
microhomology (direct repeats) by mitochondrial proteins before 
joining. Even when an exact microhomology was not used, a portion 
of the direct repeat was used for the joining. The observed deletions 
FIGURE 6: Mitochondrial DNA ligase III, but not ligase IV, is required for mitochondrial EJ inside the cells. 
(A) Immunoblot analyses showing the purity of cytosolic extracts (CEs) and mitochondrial protein extracts (MEs) 
prepared from HeLa cells transfected with antisense DNA ligase III plasmid. We used ∼15-μg extracts from HeLa cells 
(CE, ME, and CFE) for immunoblotting. Cytochrome C, PCNA, and β-actin were used as mitochondrial, nuclear, and 
CFE markers, respectively. (B) Immunoblot analysis showing knockdown of DNA ligase III from HeLa cells and its 
quantification. For quantification, expression in MOCK ME was taken as 100, and relative expression in AS L3 ME was 
calculated. β-Actin was used as a loading control. (C) MMEJ assay using HeLa mitochondrial extracts prepared from 
mock and antisense DNA ligase III–transfected cells on 13-nt microhomology–containing DNA substrates. Bar diagram 
showing relative reduction in MMEJ efficiency in antisense DNA ligase III–transfected cells compared with the mock 
transfection. (D) Immunoblot analysis showing knockdown of DNA ligase IV in HeLa cells transfected with mock and 
antisense DNA ligase IV plasmid. Tubulin was used as internal loading control. (E) Comparison of MMEJ in mitochondrial 
extracts after knockdown of ligase IV in HeLa. MMEJ activity in CFE served as the control. (F) Bar diagram showing 
relative reduction in C-NHEJ but not in MMEJ efficiency in antisense DNA ligase IV–transfected cells compared with the 
control transfection shown in D. *p < 0.05, **p < 0.01, ***p < 0.001.
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and SS105 with SS106, respectively. After end joining, junctions 
were PCR amplified using radiolabeled primer SS60 and unlabeled 
SS61.
Preparation of cell-free extracts
Cell-free extracts were prepared in ice-cold conditions as described 
(Baumann and West, 1998). Refer to the Supplemental Methods for 
more details.
Preparation of mitochondrial protein extracts from brain, 
testes, spleen, and kidney of rats and HeLa cells
Mitochondrial protein extracts were prepared by two independent 
methods. In the first, mitochondria were isolated based on differen-
tial centrifugation as described (Maianski et al., 2004; Wieckowski 
et al., 2009), with modifications. In brief, the brain, testes, spleen, 
and kidney were dissected from 3- to 5-wk-old male Wister rats 
using standard dissection procedures, and extraction was done at 
4°C or on ice. Each tissue was minced independently with a sterile 
scalpel and washed three times in ice-cold phosphate-buffered sa-
line. Homogenization buffer (70 mM sucrose, 200 mM mannitol, 
1 mM EDTA, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid, pH 7.4, and 0.5% bovine serum albumin per gram of tissue) 
was added and homogenized in a Dounce-type homogenizer 
applying 20–30 strokes. The homogenate was then centrifuged 
(3000 rpm, 10 min at 4°C) to remove nuclei, cellular debris, and in-
tact cells. The supernatant contained the cytosol and mitochondria. 
This step was repeated at least three times to avoid nuclear con-
tamination in the cytosolic fraction. The cytosolic fraction was then 
centrifuged at 12,000 rpm (30 min at 4°C) to pellet the mitochon-
dria. The mitochondrial pellet was washed in suspension buffer 
(10 mM Tris-HCl, pH 6.7, 0.15 mM MgCl2, 0.25 mM sucrose, 1 mM 
phenylmethylsulfonyl fluoride [PMSF], and 1 mM dithiothreitol 
[DTT]) twice and lysed in mitochondrial lysis buffer (50 mM Tris-HCl, 
pH 7.5, 100 mM NaCl, 10 mM MgCl2, 0.2% Triton X-100, 2 mM 
ethylene glycol tetraacetic acid, 2 mM EDTA, 1 mM DTT, and 10% 
glycerol) by mixing end over end for 30 min at 4°C along with prote-
ase inhibitors (PMSF [1 mM] and aprotinin, pepstatin, and leupeptin 
[1 μg/ml]). Mitochondrial extract was centrifuged at 12,000 rpm 
(5 min), and the supernatant (mitochondrial fraction) was aliquoted, 
snap frozen, and stored at −80°C till use.
Alternatively, mitochondrial protein extracts were also prepared 
from rat tissues and HeLa cells as per manufacturer’s instructions 
using the Mitochondrial Extraction Kit (Imgenex) and differential 
centrifugation.
In vitro C-NHEJ assay
C-NHEJ reactions were performed as described earlier (Kumar 
et al., 2010; Sharma et al., 2011; Srivastava et al., 2012). Refer to the 
Supplemental Methods for more details.
MMEJ assay
MMEJ reactions were performed as described previously (Chiruvella 
et al., 2012; Sharma et al., 2015). Reactions were carried out in a 
volume of 20 μl by incubating DNA substrates containing 13-nt mi-
crohomology (SS69/70 and SS71/72) in a buffer containing 50 mM 
Tris-HCl (pH 7.6), 20 mM MgCl2, 1 mM DTT, 1 mM ATP, and 10% 
polyethylene glycol at 25°C for 2 h. We used 5-μg mitochondrial 
extracts per reaction. The MMEJ reactions were terminated by heat 
denaturation at 65°C for 5 min. The end-joined products were PCR 
amplified using radiolabeled primer SS60 and unlabeled SS61. The 
PCR products were resolved on 8% PAGE and quantified as 
described.
characteristic features of the observed MMEJ in mitochondria are 
similar to those observed during mitochondrial deletions in patient 
samples. During MMEJ, an exonuclease-mediated deletion of one 
of the two strands of DNA from DSB exposes the microhomology 
region, followed by annealing of the repeat, removal of the flap by 
endonuclease, and final sealing by ligase III, resulting in a rear-
ranged product (Sharma et al., 2015).
A majority of mtDNA deletions observed in vivo span direct 
DNA repeat sequences 5–13 base pairs in length (Tanhauser and 
Laipis, 1995; Van Tuyle et al., 1996). In our studies, we found that a 
minimum length of 5-nt microhomology was necessary for efficient 
MMEJ in mitochondria. In addition, efficiency of the joining im-
proved when the length of the microhomology was increased to 18 
base pairs, which correlates with the in vivo data. The length of the 
deletions typically observed in mammalian mtDNA in vivo ranges 
from 2 to 7 kb (Anderson et al., 1981; Queen and Korn, 1984). These 
large deletions in patients could be the result of independent DNA 
strand breaks occurring in close vicinity to inverted repeats joined 
by MMEJ. Hence our observation of small microhomology use is 
particularly relevant. Given the collective results, the MMEJ ob-
served in our studies provides a potential mechanism for the gene-
sis of mitochondrial DNA deletions seen in specific mitochondrial 
disorders. We suggest that understanding the pathological basis for 
these breaks warrants further investigation.
MATERIALS AND METHODS
Plasmid constructs
The antisense expression plasmids pREP-hLIGIII and pREP-hLIGIV 
were kind gifts from Colin R. Campbell (University of Minnesota).
Oligomers
The oligomers were purified using 8–15% denaturing PAGE as de-
scribed (Nambiar et al., 2013). The 5′ end labeling of the oligomeric 
DNA was performed as previously described (Nambiar et al., 2013), 
using T4 polynucleotide kinase in appropriate buffer containing [γ-
32P]ATP at 37°C for 1 h. The labeled substrates were purified using 
G-25 Sephadex columns and stored at −20°C until use. See Supple-
mental Table S1 for the oligomers used.
Preparation of DNA substrates for C-NHEJ and MMEJ
For C-NHEJ studies, oligomeric DNA substrates (75 base pairs) con-
taining 5′-compatible overhangs were prepared by annealing a γ-
32P-labeled TSK1 with cold complementary oligomer TSK2 (1:3 ra-
tio) by slow annealing in the presence of 100 mM NaCl and 1 mM 
EDTA as described (Naik et al., 2010). Double-stranded DNA con-
taining 5′-5′ and 5′-3′ noncompatible overhangs were prepared by 
mixing radiolabeled TSK1 with cold complementary oligomers 
VK11 and VK13, respectively. Blunt-ended DNA substrate was pre-
pared by annealing radiolabeled VK7 with cold VK8. For MMEJ 
studies, substrates containing 13-nt microhomology were prepared 
by annealing SS69 with SS70 and SS71 with SS72, respectively, as 
mentioned (Chiruvella et al., 2012; Sharma et al., 2015). The 8-nt 
microhomology region substrates where the microhomology region 
was positioned 8 nt from DNA ends were generated by annealing 
SS56 with SS57 and SS67 with SS68, respectively. The 8-nt micro-
homology substrates positioned 24 and 8 nt, respectively, from 
DNA ends were prepared by annealing SS67 with SS68 and SS103 
with SS104. The 8-nt microhomology substrates positioned 8 and 
24 nt, respectively, from DNA ends were prepared by annealing 
SS56 with SS57 and SS105 with SS106. The 8-nt microhomology 
substrates where the microhomology region was positioned 24 nt 
away from DNA ends were prepared by annealing SS103 with SS104 
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PCR amplification, cloning, and sequencing of end-joined 
junctions
After MMEJ reactions, end-joined junctions were PCR amplified, 
and products were resolved on 8% denaturing PAGE, dried, ex-
posed, and scanned. The band of interest was cut out from PAGE 
and DNA eluted in a solution containing Tris/EDTA and NaCl (0.5 M). 
Gel-purified PCR products were ligated into a TA vector at 16°C for 
16 h. Deproteinized ligated products were used for transformation 
of Escherichia coli. Plasmid DNA was isolated from the clones of 
interest. The presence of insert was verified by restriction enzyme 
digestion and confirmed by DNA sequencing (SciGenom, India).
Immunoprecipitation
IP experiments were performed as described, with modifications 
(Chiruvella et al., 2012). Protein G agarose beads (Sigma-Aldrich, St. 
Louis, MO) were activated by immersion in water and incubated in 
IP buffer (300 mM NaCl, 20 mM Tris-HCl, pH 8.0, 0.1% NP-40, 2 mM 
EDTA, 2 mM EGTA, and 10% glycerol) for 30 min on ice, after which 
the beads were conjugated with appropriate antibody at 4°C over-
night to generate antibody–bead conjugate. The antibody–bead 
conjugates were then separated by centrifugation and incubated 
with rat tissue mitochondrial extracts at 4ºC overnight. The conju-
gate bound to target proteins was then separated and washed. Pro-
tein depletion in the resulting supernatant was confirmed by immu-
noblot analysis and quantified using Multi Gauge (version 3.0). 
These immunodepleted extracts were used for MMEJ assays 
(Sharma et al., 2015).
Evaluation of effect of DSB repair inhibitors on MMEJ
Various DSB repair inhibitors were prepared as follows. ATM kinase 
inhibitor KU55933, DNA-PK inhibitor NU7026, ligase I inhibitor L82, 
PI3K inhibitor wortmannin, and MRE11 inhibitor mirin (all from 
Sigma-Aldrich) were dissolved in dimethyl sulfoxide (DMSO) to 
make 100 mM stock solutions. For the PARP1 inhibitor 3-ABA 
(Sigma-Aldrich), 300 mM stock solutions were prepared in DMSO. 
For evaluation of the effect of inhibitors on MMEJ, 2-μg mitochon-
drial extracts (rat testes) were preincubated with increasing concen-
tration of inhibitors (10 μM to 10 mM) for 30 min on ice and sub-
jected to end joining (2 h at 25°C), and the products were analyzed 
as described. In the case of control reactions for which inhibitor was 
not added, the highest concentration of DMSO was used.
Antisense RNA-mediated knockdown of expression of 
ligase III and ligase IV
DNA ligase III and DNA ligase IV antisense expression plasmids 
(∼20 μg) were transfected into human HeLa cells using the calcium 
phosphate method (Raghavan et al., 2005; Naik and Raghavan, 
2012; Kumari and Raghavan, 2015). Cells were grown for 48 h in 
MEM supplemented with 10% fetal bovine serum and 1% penicillin-
streptomycin (Sigma-Aldrich) and were harvested for preparation of 
small-scale whole-cell or mitochondrial extracts.
Preparation of small-scale mitochondrial extracts 
from HeLa cells
Small-scale extracts were prepared as described with slight modifi-
cations (Smeaton et al., 2007). Refer to the Supplemental Text for 
more details.
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